Atlas Trials

A Pilot Study for the Treatment of Iris Neovascularization With Macugen

Clinical trial NCT00295828 · COMPLETED

Trial details

NCT number
NCT00295828
Sponsor
Hermann Eye Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Iris NeovascularizationDiabetic Retinopathy
Start date
2006-01-01
Primary completion
2008-09-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.